1.96
price up icon1.55%   0.03
after-market Handel nachbörslich: 1.95 -0.01 -0.51%
loading

Finanzdaten der Vor Biopharma Inc-Aktie (VOR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
723.90%
274.28
33.29 31.31 28.51 29.04
Operating Income/Loss
723.90%
-274.28
-33.29 -31.31 -28.51 -29.04
Nonoperating Income/Loss
161.51K%
-1,299.38
0.805 0.599 0.954 1.196
Income/Loss From Continuing Operations Before Tax
4,744%
-1,573.67
-32.49 -30.71 -27.56 -27.84
Income/Loss From Continuing Operations After Tax
4,744%
-1,573.67
-32.49 -30.71 -27.56 -27.84
Net Income/Loss
4,744%
-1,573.67
-32.49 -30.71 -27.56 -27.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.36%
125.27
124.82 0.4396 68.47 68.30
Diluted Average Shares
0.36%
125.27
124.82 0.4396 68.47 68.30
Basic Earnings Per Share
4,731%
-12.56
-0.26 -0.44 -0.40 -0.41
Diluted Earnings Per Share
4,731%
-12.56
-0.26 -0.44 -0.40 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):